CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...

Get ready for a busy two work weeks on Capitol Hill. Everyone has their eye on the Memorial Day weekend prize. In today’s ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

The executive order directs Trump's administration to take actions against "discriminatory" policies in foreign countries ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

The Trump plan won't be limited to Medicare prescriptions and will also target medications covered by Medicaid and private ...